Week ending July 16: POINT Biopharma Global Inc. (PNT:NAQ) shares steady

Public Policy
Stock market 18 edited

ORGANIZATIONS IN THIS STORY

LETTER TO THE EDITOR

Have a concern or an opinion about this story? Click below to share your thoughts.
Send a message

Community Newsmaker

Know of a story that needs to be covered? Pitch your story to The Business Daily.
Community Newsmaker

Shares in POINT Biopharma Global Inc. (PNT:NAQ), based in Indianapolis, were steady on Wall Street in the week ending July 16.

The lowest share price reached in the week was $7.81 compared to a high of $8.03.

POINT Biopharma Global Inc. in Indianapolis employs 72 people and has reported -$56,500,000 USD in income.

Despite a tumultuous year with the COVID-19 pandemic, the US stock market overall remained strong in 2021.

Tony Despirito at investment firm BlackRock said “Overall, companies have beat analyst expectations on both earnings per share and revenue growth. But the latter has been particularly strong.”

George Sweeney, a qualified financial advisor writing for The Motley Fool, cautioned the market will have to cool eventually, though it may not be a full crash as some predict.

“The market seems to flinch with any piece of news. My view is there could be a drop in the stock market...but only if there is some significant bad news or a global event.”

Nothing in this article is to be assumed as financial advice.

Shares are considered steady when they change within 3% both up and down during the time frame.

Share price of POINT Biopharma Global Inc. stocks in the week ending July 16

DateShare Asking Price
July 15$7.81
July 14$7.9
July 13$7.95
July 11$8.03

ORGANIZATIONS IN THIS STORY

LETTER TO THE EDITOR

Have a concern or an opinion about this story? Click below to share your thoughts.
Send a message

Community Newsmaker

Know of a story that needs to be covered? Pitch your story to The Business Daily.
Community Newsmaker

MORE NEWS